Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Trifluperidol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 3/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.72 |
| ▸ | TSHR | P16473 | 2/20 | 0.72 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.72 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.72 |
| ▸ | TP53 | P04637 | 1/20 | 0.72 |
| ▸ | PKM | P14618 | 1/20 | 0.72 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.72 |
| ▸ | THPO | P40225 | 1/20 | 0.72 |
| ▸ | MTOR | P42345 | 1/20 | 0.72 |
| ▸ | EBP | Q15125 | 1/20 | 0.72 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.71 |
| ▸ | DRD2 | P14416 | 7/20 | 0.58 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.53 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.51 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.50 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluperidol SCHEMBL29710906 | 0.85 | CYP3A4 (1.00) | CYP2D6CYP3A4TSHRSIGMAR1ABCB11 | |
| Trifluperidol SCHEMBL120862 | 0.85 | CYP3A4 (1.00) | CYP2D6CYP3A4TSHRSIGMAR1ABCB11 | |
| Trifluperidol SCHEMBL316725 | 0.84 | PMP22 (1.00) | CYP2D6CYP3A4TSHRSIGMAR1ABCB11 | |
| Trifluperidol SCHEMBL14973483 | 0.84 | PMP22 (1.00) | CYP2D6CYP3A4TSHRSIGMAR1ABCB11 | |
| Trifluperidol SCHEMBL13724801 | 0.82 | CYP3A4 (0.86) | CYP2D6CYP3A4TSHRSIGMAR1ABCB11 | |
| SCHEMBL9053345 | 0.81 | ABCB11 (0.85) | CYP2D6CYP3A4TSHRSIGMAR1ABCB11 | |
| Trifluperidol SCHEMBL28086762 | 0.79 | ABCB11 (0.88) | CYP2D6CYP3A4TSHRSIGMAR1ABCB11 | |
| Trifluperidol SCHEMBL5490310 | 0.77 | CYP3A4 (0.83) | CYP2D6CYP3A4TSHRSIGMAR1ABCB11 | |
| SCHEMBL7437497 | 0.77 | CHRM2 (0.73) | CYP2D6CYP3A4TSHRSIGMAR1PMP22 | |
| SCHEMBL8986042 | 0.76 | DRD2 (1.00) | CYP2D6CYP3A4TSHRSIGMAR1ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1460995-A4 | TRANSDERMAL TRANSPORT OF COMPOUNDS | VITAL HEALTH SCIENCES PTY LTD (AU) | 2007-11-21 | — | — | EP | disclosed |
| EP-1460995-A1 | TRANSDERMAL TRANSPORT OF COMPOUNDS | Vital Health Sciences Pty Ltd. (AU) | 2004-09-29 | — | — | EP | disclosed |
| WO-2003049774-A1 | TRANSDERMAL TRANSPORT OF COMPOUNDS | VITAL HEALTH SCIENCES PTY LTD (AU) | 2003-06-19 | — | — | WO | disclosed |